Archive for the ‘Patient information’ Category

From organ survival to organ revival – how patients can regenerate their own donor lung prior to surgery

Author: Holly Wobma, 03/22/17

For most areas of medicine, the supply of a treatment can easily meet demand (access issues aside). Need an antibody? A steroid? Millions of pills are manufactured every day. The case could not be more different for solid organ transplantation, for which the list of patients with end-stage organ failure vastly exceeds the number of…Read more

Right Turn: My question to Paul Knoepfler: Do you ever sleep?

Author: Stacey Johnson, 03/10/17

Paul Knoepfler, already well known for his prolific blogging at The Niche and for his role as a stem cell educator and tireless patient advocate – award winning no less – has taken on another project. Ask him a question about stem cells and you may get a live response. On February 26th, Dr. Knoepfler,…Read more

Right Turn: Raising awareness about spinal cerebrospinal fluid (CSF) leak

Author: Stacey Johnson, 03/03/17

Have you heard of spinal cerebrospinal fluid (CSF) leak? No? That’s why the Spinal Cerebrospinal Fluid (CSF) Leak Foundation, established in June 2014, is holding its first educational campaign (Feb. 27-March 3, 2017) to raise awareness of spinal CSF leak, an underdiagnosed cause of headaches that are easily treated and cured. If you suffer from…Read more

Right Turn: New stem cell product for ALS seeking approval in Canada

Author: Stacey Johnson, 02/24/17

This week, BrainStorm Cell Therapeutics issued a news release announcing its intent to seek early regulatory approval to distribute its Amyotrophic Lateral Sclerosis (ALS) product to patients in Canada. This news was eagerly received by patient groups in Canada and internationally. ALS, also known as Lou Gehrig’s Disease, is a progressive neuromuscular disease in which…Read more

Can we use animals as living incubators for human tissue?

Author: Jovana Drinjakovic, 01/16/17

Markus Grompe certainly thinks so and is working hard to make it happen. A scientist and a pediatrician specializing in inborn liver diseases, Dr. Grompe has a plan for overcoming the shortage of organ donors—the key obstacle for patients for whom the liver transplant is the only hope. Based at the Oregon Health and Science…Read more

Crazy for CRISPR!

Author: Sara M. Nolte, 12/05/16

On November 15th, my social media pages exploded with posts and comments regarding the latest news about how the gene-editing ‘CRISPR-Cas9’ technology had been used in the first human patient. The article, published by Nature, was entitled “CRISPR gene-editing tested in a person for the first time.” It described how a group of Chinese scientists…Read more

Lobbying for deregulation of stem cell procedures is giving rise to a new “dark economy”

Author: Hamideh Emrani, 10/31/16

Day 3 of the Till & McCulloch Meetings continued with many interesting talks. The one that I have chosen to write about in more detail Dr. Douglas Sipp’s, titled “The Stem Cell Dark Economy.” I think his talk was really thought provoking, and important to be shared with our readers. He began with an old…Read more

A peek into a septic shock clinical trial and a patient’s message of hope (TMM2016-Day2)

Author: Hamideh Emrani, 10/27/16

The second day of the Till & McCulloch Meetings (TMM) kicked off with a great talk by Dr. Masayo Takahashi of the Riken Center for Developmental Biology, on the generation of retinal progeny and photoreceptors from iPSCs and ESCs. However, for today, I would like to focus on two different talks. I am sure further…Read more

Right Turn: Finding a treatment for vision loss is looking up

Author: Stacey Johnson, 10/21/16

October 13, 2016 was World Sight Day and the month of October is dedicated to blindness and vision loss awareness. No doubt that is why the California Institute for Regenerative Medicine (CIRM) recently shared the third installment in its Stem Cells in Your Face series. In the video below, narrator Kevin McCormack, whose day job…Read more

Right Turn: Finding donors for multi-ethnic patients with rare blood diseases

Author: Guest, 10/07/16

Laine Jaremey is the Communications Specialist at CCRM. Laine has over eight years of experience as a strategic communicator with a focus in the health industry. She completed her Bachelor’s Degree in Communication Studies at Wilfrid Laurier University, and a Postgraduate certificate in Public Relations from Humber College. Follow her on Twitter @LaineJaremey Being diagnosed with…Read more